Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden

BACKGROUND: Tiotropium (TIO) is a well-established bronchodilator, LAMA (long-acting anticholinergic), for the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD). Clinical evidence suggests that tiotropium is superior to usual non-LAMA care (UC) but may also have benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Eklund, Oskar, Afzal, Faraz, Borgström, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539698/
https://www.ncbi.nlm.nih.gov/pubmed/26288574
http://dx.doi.org/10.1186/s12962-015-0040-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539698/
https://www.ncbi.nlm.nih.gov/pubmed/26288574
http://dx.doi.org/10.1186/s12962-015-0040-1

Ejemplares similares